UCB Initiates Phase 1b US-Based Multicenter Clinical Trial in Parkinson’s Disease Patients with UCB0599, a Compound Arising from the Neuropore-UCB Collaboration
https://www.apnews.com/c222a09ec7ba4630939379d2633f6db3
https://finance.yahoo.com/news/ucb-initiates-phase-1b-us-120100721.html